The Latin American obesity intervention market will grow through 2026, driven by an increasing obese population and growth of bariatric surgery utilization as a result of positive clinical results and broader acceptance of these procedures in the region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for obesity intervention in Latin America across a 10-year period.
In several Latin American countries, sales of intragastric balloons will be bolstered by improved physician marketing and awareness.
Which countries will experience the greatest increase in balloon sales?
Which companies successfully market to physicians and what are their market shares?
Insurance coverage varies across the countries and greatly impacts the types of procedures Latin American patients choose to undergo.
How does the availability of insurance differ across the countries?
How does varying insurance coverage impact patients' choices of treatment?
Several emerging devices are expected to enter the Latin American market within the forecast period.
Which products will enter the Latin American market and when?
How does the approval process in Latin America impact which emerging products will enter the region?
- Obesity Interventions - Market Insights - Latin America
Author(s): P Prasad, MS
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG